Nazia Thakur

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Vaccination, Vaccine Safety, Phase 1/2 +7

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 446 citations · Full text

The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein

Thomas P. Peacock, Jonathan C. Brown, Jie Zhou et al. · 2022 · 291 citations · Full text

Viral Pathogenesis, Immunology, Immunodominance +19

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen et al. · Nature Communications · 2021 · 283 citations · Full text

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Steven A. Kemp, Bo Meng, Isabella ATM Ferriera et al. · 2020 · 224 citations · Full text

Viral Pathogenesis, Immunology, Immunodominance +16